However, implementation of eryptosis assays in nanotoxicology can be limited by the lack of a generally accepted single eryptosis marker and the requirements to use several markers simultaneously, their lower cost-effectiveness compared to the hemolysis assays, and the availability of the equipment, since eryptosis detection is primarily flow cytometry-based
Long-term AAS use has been linked to glomerular hypertrophy and focal segmental glomerulosclerosis, likely secondary to hyperfiltration, systemic hypertension, and dyslipidaemia
You may be at higher risk if you: Follow a vegan or vegetarian diet Eat very little meat, fish, eggs, or dairy Are over the age of 50 Have digestive conditions affecting absorption Take certain medications, such as metformin or acid-reducing medicines Have had certain stomach or bowel surgery Have pernicious anaemia or absorption problems People in higher-risk groups may benefit from advice, testing, or treatment depending on their symptoms and medical history
This aligns with user reports of stabilized improvements by month 4
Microneedling increases absorption 10-fold